Health
Australian firm says its nasal spray reduced coronavirus growth in animal study – The Tribune
Ena Respiratory ready to test INNA-051 in human trials in less than four months
Sydney, September 28
Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly reduced the growth of the coronavirus in a recent study on animals.
A study on ferrets showed the product dubbed INNA-051, which could be used complementary to vaccines, lowered the levels of the virus that causes COVID-19 by up to 96%, the company said.
The study was led by British government agency Pu…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Business20 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
General24 hours agoFederal politics live: Government says RBA rate cut decision about ‘pace, not direction’
-
General23 hours agoReserve Bank board still looking for yesterday’s news